TY - JOUR
T1 - New approaches to treating early lung cancer
AU - Roth, Jack A.
PY - 1992/5/1
Y1 - 1992/5/1
N2 - The survival from lung cancer has not changed over the past 15 years, despite the intensive application of combined modality therapy for advanced disease. Prevention and early diagnosis appear to be the most promising strategies for reduction of lung cancer mortality. A Keystone Colloquium was held April 1 to 7, 1991, on the Biology of and Novel Therapeutic Approaches for Epithelial Cancers of the Aerodigestive Tract, to discuss recent basic and clinical research in this area. This paper summarizes the presentations relevant to lung cancer, including genetic mechanisms, growth factors, neuropeptides, growth and differentiation, carcinogenesis, chemoprevention, multidrug resistance, and immunology.
AB - The survival from lung cancer has not changed over the past 15 years, despite the intensive application of combined modality therapy for advanced disease. Prevention and early diagnosis appear to be the most promising strategies for reduction of lung cancer mortality. A Keystone Colloquium was held April 1 to 7, 1991, on the Biology of and Novel Therapeutic Approaches for Epithelial Cancers of the Aerodigestive Tract, to discuss recent basic and clinical research in this area. This paper summarizes the presentations relevant to lung cancer, including genetic mechanisms, growth factors, neuropeptides, growth and differentiation, carcinogenesis, chemoprevention, multidrug resistance, and immunology.
UR - http://www.scopus.com/inward/record.url?scp=0026776425&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026776425&partnerID=8YFLogxK
M3 - Article
C2 - 1562995
AN - SCOPUS:0026776425
SN - 0008-5472
VL - 52
SP - 2652s-2657s
JO - Cancer Research
JF - Cancer Research
IS - 9 SUPPL.
ER -